Details of the Drug
General Information of Drug (ID: DMRM1QV)
Drug Name |
Tenocyclidine
|
|||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
TENOCYCLIDINE; thienyl cyclohexylpiperidine; Tenocyclidinum; Tenociclidina; 1-(1-(2-Thienyl)cyclohexyl)piperidine; Tenocyclidine [INN]; 21500-98-1; UNII-8BQ45Q6VCL; Tenocyclidinum [INN-Latin]; 1-[1-(2-thienyl)cyclohexyl]piperidine; 8BQ45Q6VCL; Tenociclidina [INN-Spanish]; CHEMBL279676; Piperidine, 1-(1-(2-thienyl)cyclohexyl)-; DEA No. 7470; Thiophene analog of phencyclidine; CHEBI:64610; 2-Thienyl analog of phencyclidine; JUZZEWSCNBCFRL-UHFFFAOYSA-N; BRN 1246605; 1-(1-[2-Thienyl]cyclohexyl)piperidine; NCGC00160467-01
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Drug Type |
Small molecular drug
|
|||||||||||||||||||
Structure |
![]() |
|||||||||||||||||||
3D MOL | 2D MOL | |||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 249.4 | ||||||||||||||||||
Topological Polar Surface Area (xlogp) | 3.9 | |||||||||||||||||||
Rotatable Bond Count (rotbonds) | 2 | |||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 0 | |||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 2 | |||||||||||||||||||
Chemical Identifiers |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
|||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | ||||||||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||||||||
References